Smartphone App-assisted PPI

Last updated: February 10, 2025
Sponsor: University Hospital, Basel, Switzerland
Overall Status: Completed

Phase

N/A

Condition

Heartburn (Pediatric)

Colic

Heartburn

Treatment

App-based treatment support

Clinical Study ID

NCT06094062
2022-00588
  • Ages > 18
  • All Genders

Study Summary

Proton pump inhibitors (PPIs) are frequently prescribed for 30 days but taken infinitely. PPIs belong to the most often inappropriate medicines (PIMs). Correct intake of medicines (named adherence) can be supported by digital devices such as smartphone applications. The goal of this interventional study is to test the feasibility of an app-based treatment support provided by community pharmacists in patients prescribed a short-term PPI (30 days). The intervention consists in tracking medication intake, symptom course and well-being over the treatment duration of 30 days with the mednet app on patients' personal smartphones.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • is ≥18 years old;

  • has symptoms that suggest or correspond to gastroesophageal reflux disease (GERD);

  • is newly prescribed a short-term PPI treatment;

  • accepts to use of the smartphone app mednet during the study period;

  • signs the informed consent form;

  • understands and speaks (Swiss) German.

Exclusion

Exclusion Criteria:

  • in the opinion of the pharmacist or physician, unlikely to comply with the studyschedule or are unsuitable for any other reason.

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: App-based treatment support
Phase:
Study Start date:
September 05, 2023
Estimated Completion Date:
January 15, 2025

Study Description

This is an exploratory study in a primary care setting with community pharmacists recruiting patients who are newly prescribed a PPI for a short-term treatment (30 days). There is no control group and no randomization. After informed consent and installing the app on their personal smartphones, patients will answer three questions from the app once daily. The questions address medication intake (yes/no), symptom course (better, worse, identical, no symptoms) and well-being (satisfactory/needs improvement). Worsening of symptoms will trigger an alarm (via email) at the pharmacy. The pharmacist will call the patients and use information from adherence and well-being to consolidate a supporting counseling.

Feasibility and a frequency estimation of the interventions will be the focus of the study in view of a larger implementation study with community pharmacies. Further implementation outcomes will be assessed through interviews and surveys (satisfaction, interprofessional work).

Connect with a study center

  • Goldene Engel Apotheke

    Basel, Basel-Stadt 4001
    Switzerland

    Site Not Available

  • TopPharm Apotheke am Spalebärg

    Basel, Basel-Stadt 4051
    Switzerland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.